Palmero, Lolita M.

HRN: 21-71-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2022
CEFUROXIME 750MG (VIAL)
08/01/2022
08/08/2022
IV
1.5G
Q8h
Acute Cholecystitis
Waiting Final Action 
08/01/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/01/2022
08/08/2022
IV
500
Q8h
Acute Cholecystitis
Waiting Final Action 
08/04/2022
CEFUROXIME 500MG (TAB)
08/04/2022
08/10/2022
PO
500mg
Q8hrs
Post-op
Waiting Final Action 
08/04/2022
METRONIDAZOLE 500MG (TAB)
08/04/2022
08/10/2022
PO
500mg
Q8hrs
Post-op
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: